Chemotherapy-Induced IL34 Enhances Immunosuppression by Tumor-Associated Macrophages and Mediates Survival of Chemoresistant Lung Cancer CellsMuhammad Baghdadi, Ken‐ichiro Seino, Tomoyuki Yokose et al.|Cancer Research|2016Cited by 178
High co-expression of IL-34 and M-CSF correlates with tumor progression and poor survival in lung cancersMuhammad Baghdadi, Ken‐ichiro Seino, Hiraku Endo et al.|Scientific Reports|2018Cited by 116
Myeloid molecular characteristics of human γδ T cells support their acquisition of tumor antigen-presenting capacityMasato Muto, Ken‐ichiro Seino|Cancer Immunology Immunotherapy|2015Cited by 48
Interleukin-34 expression in ovarian cancer: a possible correlation with disease progressionHiraku Endo, Ken‐ichiro Seino, Naoki Hama et al.|International Immunology|2019Cited by 32
Prognostic value of IL-34 in colorectal cancer patientsTakuto Kobayashi, Ken‐ichiro Seino, Muhammad Baghdadi et al.|Immunological Medicine|2019Cited by 21